DR. (MRS.) RENUKA DATLA vs SOLVAY PHARMACEUTICAL B.V. .

The Supreme Court addressed a dispute between shareholders of two pharmaceutical companies regarding the transfer of shareholdings. The Court upheld the terms of a mutual settlement reached by the parties, which included the valuation of shares held by the petitioners in Duphar Pharma India Ltd. and Duphar Interfran Ltd. The Court mandated that the valuation be completed within four weeks and be conducted by a Chartered Accountant, with the valuation being final and binding. The Court's holding emphasized the importance of adhering to the settlement terms and the procedural requirements for share transfer under the Companies Act.